- Home
- NAMS vs CRNX Comparison
NAMS vs CRNX Comparison
Compare NAMS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- CRNX
- Stock Information
- Founded
- NAMS 2019
- CRNX 2008
- Country
- NAMS Netherlands
- CRNX United States
- Employees
- NAMS N/A
- CRNX N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- NAMS Health Care
- CRNX Health Care
- Exchange
- NAMS Nasdaq
- CRNX Nasdaq
- Market Cap
- NAMS 2.7B
- CRNX 2.8B
- IPO Year
- NAMS N/A
- CRNX 2018
- Fundamental
- Price
- NAMS $27.00
- CRNX $35.61
- Analyst Decision
- NAMS Strong Buy
- CRNX Strong Buy
- Analyst Count
- NAMS 10
- CRNX 7
- Target Price
- NAMS $41.40
- CRNX $74.33
- AVG Volume (30 Days)
- NAMS 872.1K
- CRNX 1.0M
- Earning Date
- NAMS 08-06-2025
- CRNX 08-07-2025
- Dividend Yield
- NAMS N/A
- CRNX N/A
- EPS Growth
- NAMS N/A
- CRNX N/A
- EPS
- NAMS N/A
- CRNX N/A
- Revenue
- NAMS $64,006,000.00
- CRNX $1,392,000.00
- Revenue This Year
- NAMS N/A
- CRNX $489.51
- Revenue Next Year
- NAMS N/A
- CRNX $661.93
- P/E Ratio
- NAMS N/A
- CRNX N/A
- Revenue Growth
- NAMS 762.15
- CRNX 0.51
- 52 Week Low
- NAMS $14.06
- CRNX $24.10
- 52 Week High
- NAMS $27.29
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- NAMS 67.63
- CRNX 70.32
- Support Level
- NAMS $24.41
- CRNX $30.25
- Resistance Level
- NAMS $25.65
- CRNX $35.21
- Average True Range (ATR)
- NAMS 1.10
- CRNX 1.41
- MACD
- NAMS 0.05
- CRNX 0.65
- Stochastic Oscillator
- NAMS 98.63
- CRNX 95.62
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.